Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
What If Ventures
FriscoPre-Seed–Late Stage
1 person
Quad Ventures
SeoulPre-Seed–Late Stage
4 people
Southlight Capital
Mexico CitySeed–Late Stage
4 people
Alpha Sigma Capital
El SegundoSeed–Growth
5 people
INP Capital
VancouverSeed–Late Stage
5 people
LOUD Capital
Seed–Growth
5 people
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
11 people
Pivotal Life Sciences
Seed–Late Stage
5 people
Princeville Capital
San FranciscoSeries A–Late Stage
11 people
Saisei Ventures
CambridgePre-Seed–Growth
5 people
Horizon Technology Finance
FarmingtonGrowth–Late Stage$3M – $50M
2 people
KittyHawk Ventures
Silicon ValleySeed–Late Stage$250K – $15M
2 people
Klein & Partners AG
ZugGrowth–Late Stage$550K – $5.5M
2 people
London & Scottish Investment Partners
EdinburghSeed–Growth$130K – $320K
2 people
W&W brandpool GmbH
KornwestheimPre-Seed–Growth$540K
2 people
AOKI LABS
Los AngelesPre-Seed–Growth
1 person
JourneyOne Ventures
BoulderPre-Seed–Growth
1 person
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
Exit 156 Capital
CollegevilleGrowth–Late Stage
3 people
Waterpoint Lane
MiamiSeed–Late Stage
2 people
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
7 people
First Venture
StockholmSeed–Growth
4 people
Air Liquide Venture Capital (ALIAD)
ParisSeed–Growth
EA Group Holding
AlmatyPre-Seed–Growth$1.7M – $2M
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.






















